These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1516865)

  • 1. [Treatment of malignant diseases with synthetic oligonucleotides].
    Rechavi G; Mandel M
    Harefuah; 1992 Aug; 123(3-4):133-8. PubMed ID: 1516865
    [No Abstract]   [Full Text] [Related]  

  • 2. Antisense oligonucleotides as therapeutics for malignant diseases.
    Ho PT; Parkinson DR
    Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potential role for antisense oligonucleotide analogues in the development of oncogene targeted cancer chemotherapy.
    Tidd DM
    Anticancer Res; 1990; 10(5A):1169-82. PubMed ID: 2241097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Suppression of expression of bcl-2 and bcl-xL genes using antisense oligonucleotides: a new approach to cancer therapy].
    Lebedeva IV; Staĭn SA
    Mol Biol (Mosk); 2000; 34(6):1025-38. PubMed ID: 11186002
    [No Abstract]   [Full Text] [Related]  

  • 5. [Approach to human glioma cells using antisense molecules].
    Yoshida S; Tanaka R
    No To Shinkei; 1995 Sep; 47(9):823-8. PubMed ID: 7546930
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antisense against cancer?]].
    Edris E; Möller AM; Oberhauser EM; Zündorf I; Dingermann T
    Pharm Unserer Zeit; 2010 May; 39(3):170-1. PubMed ID: 20425764
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeting tumor cell resistance to apoptosis induction with antisense oligonucleotides: progress and therapeutic potential.
    Olie RA; Zangemeister-Wittke U
    Drug Resist Updat; 2001 Feb; 4(1):9-15. PubMed ID: 11512155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic potential of antisense oligonucleotides.
    Sharma HW; Narayanan R
    Bioessays; 1995 Dec; 17(12):1055-63. PubMed ID: 8634067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of human papillomavirus type 18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines.
    Steele C; Cowsert LM; Shillitoe EJ
    Cancer Res; 1993 May; 53(10 Suppl):2330-7. PubMed ID: 7683572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antisense nucleotides for therapy].
    Wang J; Wang L; Wang Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Feb; 23(1):230-4. PubMed ID: 16532848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense oligonucleotides.
    Herdewijn P
    Verh K Acad Geneeskd Belg; 1996; 58(4):359-81. PubMed ID: 8956554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of transplantation tolerance by treatment with ICAM-1 antisense oligonucleotides and anti-LFA-1 monoclonal antibodies.
    Stepkowski SM; Tu Y; Condon TP; Bennett CF
    Transplant Proc; 1995 Feb; 27(1):113. PubMed ID: 7878822
    [No Abstract]   [Full Text] [Related]  

  • 13. Liposomal antisense oligonucleotides for cancer therapy.
    Siwak DR; Tari AM; Lopez-Berestein G
    Methods Enzymol; 2004; 387():241-53. PubMed ID: 15172168
    [No Abstract]   [Full Text] [Related]  

  • 14. Antisense oligonucleotides directed at cell cycle regulatory genes as strategy for restenosis therapy.
    Morishita R; Gibbons GH; Ellison KE; Nakajima M; von der Leyen H; Zhang L; Kaneda Y; Ogihara T; Dzau VJ
    Trans Assoc Am Physicians; 1993; 106():54-61. PubMed ID: 8036745
    [No Abstract]   [Full Text] [Related]  

  • 15. A hitchhiker's guide to antisense and nonantisense biochemical pathways.
    Branch AD
    Hepatology; 1996 Dec; 24(6):1517-29. PubMed ID: 8938189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense molecules for targeted cancer therapy.
    Wacheck V; Zangemeister-Wittke U
    Crit Rev Oncol Hematol; 2006 Jul; 59(1):65-73. PubMed ID: 16750913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential use of radiolabeled antisense oligonucleotides in oncology.
    Gauchez AS; Du Moulinet D'Hardemare A; Lunardi J; Vuillez JP; Fagret D
    Anticancer Res; 1999; 19(6B):4989-97. PubMed ID: 10697501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense oligonucleotide therapy in cancer.
    Stephens AC; Rivers RP
    Curr Opin Mol Ther; 2003 Apr; 5(2):118-22. PubMed ID: 12772500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Not nonsense but antisense--applications of antisense oligonucleotides in different fields of medicine.
    Oberbauer R
    Wien Klin Wochenschr; 1997 Jan; 109(2):40-6. PubMed ID: 9123943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of antisense oligonucleotides in vivo: stability and internalization of hydrophobized oligonucleotides.
    de Falco S; Boutorine A; de Smidt C; van Berkel T; Saison E; Hélène C; Le Doan T
    Nucleic Acids Symp Ser; 1991; (24):157-8. PubMed ID: 1841272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.